辉瑞据称接近收购Metsera
PfizerPfizer(US:PFE) Ge Long Hui A P P·2025-09-22 03:59

Core Viewpoint - Pfizer is nearing a $7.3 billion acquisition of the weight-loss drug company Metsera, offering $47.5 per share in cash [1] Group 1 - Pfizer's acquisition price for Metsera is set at $47.5 per share in cash [1] - The total value of the acquisition is approximately $7.3 billion [1]